ESR1 and breast carcinoma: The observation from the Breast Cancer Prevention Trial of the National Surgical Adjuvant Breast and Bowel Project showed that TAM markedly reduced the risk of invasive breast cancer, particularly tumors with positive estrogen receptor status.